Subscribe to our updates:

Today on the HillHealth Policy ReportFinancial Services Report

Please leave this field empty.


TRP Health Policy’s mission is to help people be healthy, and we understand that is the essence of your mission too. To get there in this rapidly evolving policy space, you need both political heft and substantive depth. That’s why we deliver insightful, actionable analysis and sophisticated, informed advocacy to help you achieve your goals.

The result: a government affairs partner that actually understands this stuff, empowering clients to get their answers first, understand them better, and act on them with unparalleled confidence and precision.


Featured Services

This is where we put the *know* in TRP Health Policy, and in you. Nowhere else will you find every reg, every hearing, every grant, every ACA section, every topic, every policy development broken down for you, with careful analysis and insight you can act on - now.

Contact Us


Our promise: you will understand every policy impacting your specific goals and be fully prepared to respond. We don’t sit back waiting for your call – keeping you one step ahead is our job. Our personalized, concierge service will give you the strongest platform for building your policy success.

  • Unlimited access to Policy Hub with real-time delivery of relevant materials
  • Personalized impact analysis of legislative and regulatory changes
  • Strategic planning and strategic doing
  • Questions answered and ambiguities resolved
  • Outreach to Capitol Hill and the Administration to clarify policy developments
  • Responsive research and memoranda
  • Issue briefs addressing coverage and reimbursement of your products and services
  • In-person and telephonic conferences to ensure understanding and identify next steps
  • Preparation of advocacy materials, including regulatory comments, one-pagers, FAQs, etc.
  • Internally facing materials to help educate your own organization's audiences
  • Grant writing
  • Policy development and legislative drafting
  • Relationship development with policymakers
  • Administration meeting preparation and execution
  • Targeted advocacy with CMS, the White House, and other paramount agencies
  • Congressional lobbying
  • Cultivation and delivery of bill sponsors
  • Ally development
  • Engagement with key policy drivers such as MedPAC, GAO, CBO, etc.
  • Consolidated activity tracking with consistent reference to strategic objectives


Don’t react to policy, redefine it. With seasoned veterans of CMS and Capitol Hill’s healthcare committees, let us hone and amplify your message, ensuring it resonates with policymakers. In healthcare, it’s the right care. In policy, it’s the right message – at the right time, delivered to the right people. That’s where we excel.

Recent Analysis

Powered By:

Featured Post

Latest update from the TRP Blog

CY 2019 Medicare Advantage, Part D Proposed Rule Issued; CARA, MA Uniformity, Biosimilar Cost-Sharing, Mid-Year Generics, Any Willing Pharmacy, POS Rebate RFI Discussed

The Centers for Medicare and Medicaid Services (CMS) has released a highly anticipated proposed rule (fact sheet) addressing Contract Year (CY) 2019 Policy and Technical Changes for Medicare Advantage and Part D plans. CMS includes an assortment of proposals affecting MA and Part D plans in CY 2019. While subregulatory changes and rate updates are effectuated through the annual Call Letter... More (Zatorski, 11/16/17) #Benefit Design, #Biosimilars, #Generic Drugs, #Medicare Advantage, #Medicare Part D, #Opioids, #Pharmaceuticals, #Pharmacy, #Pharmacy Benefit Managers (PBMs)

Featured Post

Latest update from the TRP Blog

Tax Cuts and Jobs Act Passed in 227-205 Vote

The House of Representatives passed H.R. 1 – the Tax Cuts and Jobs Act (TCJA) by a vote of 227 to 205, marking a significant step forward in the Republican effort to overhaul the tax code. As expected, the bill was passed on the strength of the Republican majority, with 13 Republicans joining all voting Democrats in opposing the measure. The... More (Zatroski, 11/16/17) #Pharmaceuticals